Are you Dr. Smitt?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 17 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-498-5710
Summary
- Dr. Melanie Smitt, MD is a radiation oncologist in Stanford, California. She is currently licensed to practice medicine in California.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityResidency, Radiation Oncology, 1988 - 1991
Kaiser Permanente Northern California (Santa Clara)Internship, Internal Medicine, 1987 - 1988
Stanford University School of MedicineClass of 1987
Certifications & Licensure
CA State Medical License 1989 - 2026- American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- 19 citationsExposure-response analyses of trastuzumab emtansine in patients with HER2-positive advanced breast cancer previously treated with trastuzumab and a taxane.Chunze Li, Bei Wang, Shang-Chiung Chen, Russell D. Wada, Dan Lu
Cancer Chemotherapy and Pharmacology. 2017-10-11 - 1371 citationsTrastuzumab Emtansine for Residual Invasive HER2-Positive Breast CancerGunter von Minckwitz, Chiun Sheng Huang, Max S. Mano, Sibylle Loibl, Eleftherios P. Mamounas
The New England Journal of Medicine. 2019-02-14 - 484 citationsTrastuzumab emtansine versus treatment of physician's choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomised, open-label, phase 3 trialIan E. Krop, Sung-Bae Kim, Antonio González-Martín, Patricia LoRusso, Jean-Marc Ferrero
The Lancet. Oncology. 2014-06-01
